Cargando…

Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery

BACKGROUND: We report a case of hemorrhagic occlusive retinal vasculitis (HORV) after prophylactic intracameral vancomycin use during an uneventful cataract surgery treated with early anti-VEGF treatment. CASE PRESENTATION: A 51-year-old female underwent uneventful cataract surgery with prophylactic...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreanos, Konstantinos, Petrou, Petros, Kymionis, George, Papaconstantinou, Dimitrios, Georgalas, Ilias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719895/
https://www.ncbi.nlm.nih.gov/pubmed/29212481
http://dx.doi.org/10.1186/s12886-017-0632-y
_version_ 1783284574764138496
author Andreanos, Konstantinos
Petrou, Petros
Kymionis, George
Papaconstantinou, Dimitrios
Georgalas, Ilias
author_facet Andreanos, Konstantinos
Petrou, Petros
Kymionis, George
Papaconstantinou, Dimitrios
Georgalas, Ilias
author_sort Andreanos, Konstantinos
collection PubMed
description BACKGROUND: We report a case of hemorrhagic occlusive retinal vasculitis (HORV) after prophylactic intracameral vancomycin use during an uneventful cataract surgery treated with early anti-VEGF treatment. CASE PRESENTATION: A 51-year-old female underwent uneventful cataract surgery with prophylactic intracameral vancomycin during the procedure. On the seventh post-operative-day, she presented with sudden painful, visual loss. Fundus examination revealed peripheral hemorrhagic retinal vasculitis. She received anti-VEGF therapy to prevent further vision loss and retinal neovascularization due to extensive retinal ischemia. At the 6-month follow-up visit, visual acuity was 20/20 with no sign of neovascularization. CONCLUSIONS: Postoperative HORV is a devastating condition that can occur after otherwise uncomplicated cataract surgery. The nature of this rare condition remains unknown. Early anti-VEGF administration seems to demonstrate favorable results.
format Online
Article
Text
id pubmed-5719895
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57198952017-12-11 Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery Andreanos, Konstantinos Petrou, Petros Kymionis, George Papaconstantinou, Dimitrios Georgalas, Ilias BMC Ophthalmol Case Report BACKGROUND: We report a case of hemorrhagic occlusive retinal vasculitis (HORV) after prophylactic intracameral vancomycin use during an uneventful cataract surgery treated with early anti-VEGF treatment. CASE PRESENTATION: A 51-year-old female underwent uneventful cataract surgery with prophylactic intracameral vancomycin during the procedure. On the seventh post-operative-day, she presented with sudden painful, visual loss. Fundus examination revealed peripheral hemorrhagic retinal vasculitis. She received anti-VEGF therapy to prevent further vision loss and retinal neovascularization due to extensive retinal ischemia. At the 6-month follow-up visit, visual acuity was 20/20 with no sign of neovascularization. CONCLUSIONS: Postoperative HORV is a devastating condition that can occur after otherwise uncomplicated cataract surgery. The nature of this rare condition remains unknown. Early anti-VEGF administration seems to demonstrate favorable results. BioMed Central 2017-12-06 /pmc/articles/PMC5719895/ /pubmed/29212481 http://dx.doi.org/10.1186/s12886-017-0632-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Andreanos, Konstantinos
Petrou, Petros
Kymionis, George
Papaconstantinou, Dimitrios
Georgalas, Ilias
Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery
title Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery
title_full Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery
title_fullStr Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery
title_full_unstemmed Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery
title_short Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery
title_sort early anti-vegf treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719895/
https://www.ncbi.nlm.nih.gov/pubmed/29212481
http://dx.doi.org/10.1186/s12886-017-0632-y
work_keys_str_mv AT andreanoskonstantinos earlyantivegftreatmentforhemorrhagicocclusiveretinalvasculitisasacomplicationofcataractsurgery
AT petroupetros earlyantivegftreatmentforhemorrhagicocclusiveretinalvasculitisasacomplicationofcataractsurgery
AT kymionisgeorge earlyantivegftreatmentforhemorrhagicocclusiveretinalvasculitisasacomplicationofcataractsurgery
AT papaconstantinoudimitrios earlyantivegftreatmentforhemorrhagicocclusiveretinalvasculitisasacomplicationofcataractsurgery
AT georgalasilias earlyantivegftreatmentforhemorrhagicocclusiveretinalvasculitisasacomplicationofcataractsurgery